Immunologic Research

, 9:287 | Cite as

T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis

  • Francien T. M. Rotteveel
  • Cornelis J. Lucas
Multiple Sclerosis T Cells

Keywords

Multiple Sclerosis Experimental Autoimmune Encephalomyelitis Multiple Sclerosis Patient Myelin Basic Protein Multiple Sclerosis Susceptibility Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    McFarlin DE, McFarland HF: Multiple sclerosis. N Engl J Med 1982;307:1183–1188.PubMedGoogle Scholar
  2. 2.
    Traugott U, Reinherz EL, Raine CS: Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 1983;219:308–310.PubMedCrossRefGoogle Scholar
  3. 3.
    Hofman FM, von Hanwehr RI, Dinarello CA, et al: Immunoregulatory molecules and IL-2 receptor identified in multiple sclerosis brain. J Immunol 1986;136:3239–3245.PubMedGoogle Scholar
  4. 4.
    Hauser SL, Bhan AK, Gilles F, et al: Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 1986;19: 578–587.PubMedCrossRefGoogle Scholar
  5. 5.
    Waksman B: Mechanisms in multiple sclerosis. Nature 1985;318:104–105.PubMedCrossRefGoogle Scholar
  6. 6.
    Salmi A, Reunanen M, Ilonen J, et al: Intrathecal antibody synthesis to virus antigens in multiple sclerosis. Clin Exp Immunol 1983;52:241–249.PubMedGoogle Scholar
  7. 7.
    Woyciechowska JL, Dambrozia J, Leinikki P, et al: Viral antibodies in twins with multiple sclerosis. Neurology 1985;35:1176–1180.PubMedGoogle Scholar
  8. 8.
    Compston DAS, Vakarelis BN, Paul E et al: Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 1986;109:325–344.PubMedCrossRefGoogle Scholar
  9. 9.
    Reddy EP, Sandberg-Wollheim M, Mettus RV, et al: Amplification and molecular cloning of HTLV-1 sequences from DNA of multiple sclerosis patients. Science 1989;243:529–533.PubMedCrossRefGoogle Scholar
  10. 10.
    Waksman BH: Multiple sclerosis. Relationship to a retrovirus? Nature 1989;337:599.PubMedCrossRefGoogle Scholar
  11. 11.
    Myrianthopoulos NC: Genetic aspects of multiple sclerosis; in Koetsier JC: Handbook of Clinical Neurology. Demyelinating Diseases. Rev Ser 3. Amsterdam, Elsevier, 1985, vol 47, pp 289–317.Google Scholar
  12. 12.
    Francis DA, Batchelor JR, McDonald WI, et al: Multiple sclerosis and HLA DQw1. Lancet 1986;i: 211.CrossRefGoogle Scholar
  13. 13.
    Odum N, Hyldig-Nielsen JJ, Morling N, et al: HLA-DP antigens are involved in the susceptibility to multiple sclerosis. Tissue Antigens 1988;31: 235–237.PubMedGoogle Scholar
  14. 14.
    Beall S, Concannon P, Charmley P, et al: The germline repertoire of T cell receptor beta-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol 1989;21:59–66.PubMedCrossRefGoogle Scholar
  15. 15.
    Oksenberg JR, Sherritt M, Begovich AB, et al: T-cell receptor Vα and Cα alleles associated with multiple sclerosis and myasthenia gravis. Proc Natl Acad Sci USA 1989;86:988–992.PubMedCrossRefGoogle Scholar
  16. 16.
    Reder AT, Arnason BGW: Immunology of MS; in Koetsier JC (ed): Handbook of Clinical Neurology. Demyelinating Diseases. Rev Ser 3. Amsterdam, Elsevier, 1985, vol 47, pp 337–395.Google Scholar
  17. 17.
    Watanabe R, Wege H, ter Meulen V: Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 1983;305:150–153.PubMedCrossRefGoogle Scholar
  18. 18.
    Todriquez M, Pease LR, David CS: Immune-mediated injury of virus-infected oligodendrocytes, a model of multiple sclerosis. Immunol Today 1986;7:359–363.CrossRefGoogle Scholar
  19. 19.
    Clatch RJ, Lipton HL, Miller SD: Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed type hypersensitivity responses in TMEV-induced demyelinating diseases: Correlation with clinical signs. J Immunol 1986;136:920–927.PubMedGoogle Scholar
  20. 20.
    Lisak RP, Zweiman B: In vitro cell-mediated immunity of cerebrospinal fluid lymphocytes to myelin basic protein in primary demyelinating diseases. N Engl J Med 1977;297:850–853.PubMedGoogle Scholar
  21. 21.
    Hashim GA, Brewen M: Myelin basic protein-responsive blood T lymphocytes in patients with multiple sclerosis. J Neurosci Res 1985;13:349–355.PubMedCrossRefGoogle Scholar
  22. 22.
    Raine CS: Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984;50:608–635.PubMedGoogle Scholar
  23. 23.
    Fritz RB, Skeen MJ, Jen-Chou CH; et al: Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J Immunol 1985;134:2328–2332.PubMedGoogle Scholar
  24. 24.
    Ben-Nun A, Cohen IR: Experimental autoimmune encephalomyelitis (EAE) mediated by T cell lines: process of selection of lines and characterization of the cells. J Immunol 1982;129:303–308.PubMedGoogle Scholar
  25. 25.
    Sun D, Wekerle H: Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse antigen-presenting astrocytes. Nature 1986;320:70–72.PubMedCrossRefGoogle Scholar
  26. 26.
    Walsh MJ, Tourtellotte WW: Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA and IgM in multiple sclerosis. J Exp Med 1986;163:41–53.PubMedCrossRefGoogle Scholar
  27. 27.
    Gerhard W, Taylor A, Sandberg-Wollheim M, et al: Longitudinal analysis of three intrathecally produced immunoglobulin subpopulations in an MS patient. J Immunol 1985;134:1555–1560.PubMedGoogle Scholar
  28. 28.
    Fleischer B, Kreth HW: Clonal analysis of HLA-restricted virus-specific cytotoxic T lymphocytes from cerebrospinal fluid in mumps meningitis. J Immunol 1983;130:2187–2190.PubMedGoogle Scholar
  29. 29.
    Panitch HS, Francis GS: T-lymphocyte subsets in cerebrospinal fluid in multiple sclerosis. N Engl J Med 1982;307:560–561.PubMedGoogle Scholar
  30. 30.
    Hommes OR, Brinkman CJJ: T-cell subsets in spinal fluid of multiple sclerosis patients. J Neuroimmunol 1984;6:123–130.PubMedCrossRefGoogle Scholar
  31. 31.
    Bach MA, Martin C, Cesaro P, et al: T cell subsets in multiple sclerosis, a longitudinal study of exacerbating-remitting cases. J Neuroimmunol 1985;7:331–343.PubMedGoogle Scholar
  32. 32.
    Hauser SL, Reinherz EL, Hoban CJ, et al: CSF cells in multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T-cell subsets. Neurology 1983;33:575–578.PubMedGoogle Scholar
  33. 33.
    Polman CH, de Groot CJA, Sminia T, et al: Monunuclear cell subpopulations in cerebrospinal fluid. Acta Neurol Scand 1986;74:251–252.PubMedGoogle Scholar
  34. 34.
    Bellamy AS, Calder VL, Feldmann M, et al: The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes. Clin Exp Immunol 1995;61:248–256.Google Scholar
  35. 35.
    DeFreitas EC, Sandberg-Wollheim M, Schonely K, et al: Regulation of interleukin-2 receptors on T cells from multiple sclerosis patients. Proc Natl Acad Sci USA 1986;83:2637–2641.PubMedCrossRefGoogle Scholar
  36. 36.
    Tournier-Lasserve E, Lyon-Caen O, Roullet E, et al: IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases. Clin Exp Immunol 1987;67:581–586.PubMedGoogle Scholar
  37. 37.
    Noronha A, Richman DP, Arnason BGW: Multiple sclerosis: activated cells in cerebrospinal fluid in acute exacerbations. Ann Neurol 1985;18:722–725.PubMedCrossRefGoogle Scholar
  38. 38.
    Hafler DA, For DA, Manning ME, et al: In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 1985;312:1405–1411.PubMedGoogle Scholar
  39. 39.
    Hedlund G, Sandberg-Wollheim M, Sjögren HO: Increased proportion of CD4+CDw29+CD45R− UCHL-1+ lymphocytes in the cerebrosinal fluid of both multiple sclerosis patients and healthy individuals. Cell Immunol 1989;118:406–412.PubMedCrossRefGoogle Scholar
  40. 40.
    Serra HM, Krowka JF, Ledbetter JA, et al: Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. J Immunol 1988;140:1435–1441.PubMedGoogle Scholar
  41. 41.
    Sanders ME, Makgoba MW, Shaw S: Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 1988;9:195–199.PubMedCrossRefGoogle Scholar
  42. 42.
    Trotter JL, Clifford DB, Anderson CB, et al: Elevated serum interleukin-2 levels in chronic progressive multiple sclerosis. N Engl J Med 1988; 318:1206.PubMedGoogle Scholar
  43. 43.
    Greenberg SJ, Marcon L, Hurwitz BJ, et al: Elevated levels of soluble interleukin-2 receptors in multiple sclerosis. N Engl J Med 1988;319:1019–1020.PubMedGoogle Scholar
  44. 44.
    Rose LM, Ginsberg AH, Rothstein TL, et al: Selective loss of a subset of T helper cells in active multiple sclerosis. Proc Natl Acad Sci USA 1985; 82:7389–7393.PubMedCrossRefGoogle Scholar
  45. 45.
    Morimoto C, Hafler DA; Weiner HL, et al: Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis, analysis with anti-2H4 monoclonal antibody. N Engl J Med 1987;316:67–72.PubMedGoogle Scholar
  46. 46.
    Hafler DA, Weiner HL: In vivo labeling of blood T cells: rapid traffic into cerebrospinal fluid in multiple sclerosis. Ann Neurol 1987;21:89–93.CrossRefGoogle Scholar
  47. 47.
    Sobel RA, Hafler DA, Castro EE; et al: The 2H4 (CD45R) antigen is selectively decreased in multiple sclerosis lesions. J Immunol 1988;140:2210–2214.PubMedGoogle Scholar
  48. 48.
    Rotteveel FTM, Kokkelink I, van Walbeek HK, et al: Analysis of T cell receptor-gene rearrangement in T cells from the cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 1987;15:243–249.PubMedCrossRefGoogle Scholar
  49. 49.
    Keystone EC, Minden M, Klock R, et al: Structure of T cell antigen receptor β chain in synovial fluid cells from patients with rheumatoid arthritis. Arthritis Rheum 1988;31:1555–1557.PubMedCrossRefGoogle Scholar
  50. 50.
    Doherty PC: Cell-mediated immunity in virus infections of the central nervous system; in Raine CS (ed): Advances in Neuroimmunology. New York, Annals of the New York Academy of Sciences, 1988, vol 540, pp 229–239.Google Scholar
  51. 51.
    Hafler DA, Duby AD, Lee SJ, et al: Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1988;167: 1313–1322.PubMedCrossRefGoogle Scholar
  52. 52.
    Fink PJ, Matis LA, McElligott DL, et al: Correlations between T-cell specificity and the structure of the antigen receptor. Nature 1986;321:219–226.PubMedCrossRefGoogle Scholar
  53. 53.
    Zamvil SS, Mitchell DJ, Lee NE, et al: Predominant expression of a T cell receptor Vβ gene subfamily in autoimmune encephalomyelitis. J Exp Med 1988;167:1586–1596.PubMedCrossRefGoogle Scholar
  54. 54.
    Traugott U: Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J Neurommunol 1987;16:283–302.CrossRefGoogle Scholar
  55. 55.
    Traugott U, Lebon P. Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 1988;84:257–264.PubMedCrossRefGoogle Scholar
  56. 56.
    Wong GHW, Barlett PF, Clark-Lewis I, et al: Inducible expression of H-2 and Ia antigens on brain cells. Nature 1984;310:688–691.PubMedCrossRefGoogle Scholar
  57. 57.
    Massa PT, Schimpl A, Wecker E, et al: Tumor necrosis factor amplifies measles virus-mediated Ia induction on astrocytes. Proc Natl Acad Sci USA 1987;84:7242–7245.PubMedCrossRefGoogle Scholar
  58. 58.
    Fierz W, Endler B, Reske K, et al: Astrocytes as antigen-presenting cells. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 1985;134:3785–3793.PubMedGoogle Scholar
  59. 59.
    Beck J, Rondot P, Catinot L, et al: Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? Acta Neurol Scand 1988;78:318–323.PubMedCrossRefGoogle Scholar
  60. 60.
    Traugott U, Scheinberg LC, Raine CS: On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol 1985;8: 1–14.PubMedCrossRefGoogle Scholar
  61. 61.
    Massa PT, Ter Meulen V, Fontana A: Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1987;84:4219–4223.PubMedCrossRefGoogle Scholar
  62. 62.
    Lyman WD, Roth GA, Chiu F-C, et al: Antigen-specific T cells can mediate demyelination in organotypic central nervous system cultures. Cell Immunol 1986;102:217–226.PubMedCrossRefGoogle Scholar
  63. 63.
    Brosnan CF, Selmaj K, Raine CS: Hypothesis: a role for tumor necrosis factor in immune-mediated demylination and its relevance to multiple sclerosis. J Neuroimmunol 1988;18:87–94.PubMedCrossRefGoogle Scholar
  64. 64.
    Mogensen SC, Virelizier J-L: The interferon-macrophage alliance. Interferon 1987;8:55–84.PubMedGoogle Scholar
  65. 65.
    Stout RD, Bottomly K: Antigen-specific activation of effector macrophages by IFN gamma producing (TH1) T cell clones. J Immunol 1989;142: 760–765.PubMedGoogle Scholar
  66. 66.
    Kim J, Woods A, Becker-Dunn E., et al: Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med 1985;162:188–201.PubMedCrossRefGoogle Scholar
  67. 67.
    Mosmann TR, Cherwinski H, Bond MW, et al: Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136: 2348–2357.PubMedGoogle Scholar
  68. 68.
    Rotteveel FTM, Kokkelink I, van Lier RAW, et al: Clonal analysis of functionally distinct human CD4+ T-cell subsets. J Exp Med 1988;168:1659–1673.PubMedCrossRefGoogle Scholar
  69. 69.
    Prud'homme GJ, Parfrey NA: Biology of disease. Role of T helper lymphocytes in autoimmune disease. Lab Invest 1988;59:158–172.PubMedGoogle Scholar
  70. 70.
    Rotteveel FTM, Kuener B, Kokkkelink I, et al: A relative increases of inflammatory CD4+ T cells in the cerebrospinal fluid of both multiple sclerosis patients and control individuals. Clin Exp Immunol, in press.Google Scholar
  71. 71.
    Cavender D, Saegusa Y, Ziff M: Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol 1987;139:1855–1860.PubMedGoogle Scholar
  72. 72.
    Yu C-L, Haskard DO, Cavender D, et al: Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin Exp Immunol 1985;62:554–560.PubMedGoogle Scholar
  73. 73.
    Rothlein R, Czajkowski M, O'Neill MM, et al: Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol 1988;141:1665–1669.PubMedGoogle Scholar
  74. 74.
    Roitt IM, Dwek RA, Parekh RB, et al: The role of antigen in autoimmune responses with special reference to changes in carbohydrate structure of IgG in rheumatoid arthritis. J Autoimmun 1988;1: 499–506.CrossRefGoogle Scholar
  75. 75.
    De Carvalho LCP, Templeman J, Wick G, et al: The role of self-antigen in the development of autoimmunity in obese strain chickens with spontaneous autoallergic thyroiditis. J Exp Med 1982; 155:1255–1266.CrossRefGoogle Scholar
  76. 76.
    Weber WEJ, Buurman WA: Myelin basic protein-specific CD4+ cytolytic T-lymphocyte clones isolated from multiple sclerosis patients. Hum Immunol 1988;22:97–109.PubMedCrossRefGoogle Scholar
  77. 77.
    Bellamy A, Davison AN, Feldmann M: Derivation of ganglioside-specific T cell lines of suppressor or helper phenotype from cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 1986;12:107–120.PubMedCrossRefGoogle Scholar
  78. 78.
    Burns J, Zweiman B, Lisak R. Tetanus toxoid reactive T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. Immunol Commun 1984;13:361–369.PubMedGoogle Scholar
  79. 79.
    Fleischer B, Marquardt P, Poser S, et al: Phenotypic markers and functional characteristics of T lymphocyte clones from cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1984;6:151–162.CrossRefGoogle Scholar
  80. 80.
    Hafler DA, Benjamin DS, Burks J, et al: Myelin basic protein and proteolipid protein reactivity of brain and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postifectious encephalomyelitis. J Immunol 1987;139:68–72.PubMedGoogle Scholar
  81. 81.
    Weiner HL, Hafler DA: Immunotherapy of multiple sclerosis. Ann Neurol 1988;23:211–222.PubMedCrossRefGoogle Scholar
  82. 82.
    Ben-Nun A, Wekerle H, Cohen IR: Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. Nature 1981;292:60–61.PubMedCrossRefGoogle Scholar
  83. 83.
    Lider O, Reshef T, Beraud E, et al: Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 1988;239:181–183.PubMedCrossRefGoogle Scholar
  84. 84.
    Searles RP, Savage SM, Brozek CM, et al: Network regulation in rheumatoid arthritis. Arthritis Rheum 1988;31:834–843.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1990

Authors and Affiliations

  • Francien T. M. Rotteveel
    • 1
    • 2
  • Cornelis J. Lucas
    • 1
    • 2
    • 3
  1. 1.Central Laboratory of The Netherlands Red Cross Blood Transfusion Service of the University of AmsterdamThe Netherlands
  2. 2.Laboratory for Experimental and Clinical Immunology of the University of AmsterdamThe Netherlands
  3. 3.Medical Biological LaboratoryTNORijswijk(The Netherlands)

Personalised recommendations